Custom Enquiry
We aim to give you a response from a qualified scientist within a hour.
Review The SDS Document
DOWNLOADProduct Details
Formula
C14H30N2NaO19P4
MW
677.28
Purity
>97%
Solubility (DMSO Mg/MI)
INSOLUBLE
Storage (Powder)
3 Years -20?C
Storage (Solvent)
1 Year -80?C
Indication
N/A
Mode Of Action
inhibitor
Drug Status
Approved
Target Name
Farnesyl pyrophosphate (FPP) synthase
Research Area
ENDOCRINOLOGY
Research Area Sub Group
Bone Density Conservation
Pharmacology
ENZYMES
Pharmacology Area Sub Group
Synthase
Bio Chemical Notes
Risedronate is used to treat or prevent osteoporosis and Paget